{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:09:11Z","timestamp":1774321751158,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":149,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are the facilitators and barriers concerning the implementation of home-based monitoring for natural cycle frozen embryo transfer (NC-FET) from the perspectives of patients and healthcare providers in the Netherlands?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>The most important facilitator was optimal pregnancy chance for both the patients and healthcare providers, and the most important barriers were the risk of missing an ovulation for the patients and laboratory capacity for the healthcare providers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>The share of FET cycles in IVF treatments is increasing and, therefore, it is important to optimize protocols for FET. Monitoring of ovulation, which is used in NC-FET, can be hospital-based (ultrasounds and ovulation triggering) or home-based (LH urine tests). Home-based monitoring has the advantage of being the most natural protocol for FET and provides the feeling of empowerment and discretion for patients. A systematic approach for the implementation of home-based monitoring has to start with an exploration of the perspectives of all stakeholders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>Stakeholders (patients and healthcare providers) involved in the implementation process in the Netherlands participated in the present study. Patients were represented by the Dutch Patient Organisation for Couples with Fertility Problems (FREYA) and healthcare providers were represented by gynaecologists and their society (The Netherlands Society of Obstetrics and Gynaecology), embryologists and their society (The Dutch Federation of Clinical Embryology) as well as fertility doctors. A panel of experts hypothesized on barriers and facilitators for the implementation of home-based monitoring during the proposal phase of the Antarctica-2 randomized controlled trial (RCT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>All stakeholders were represented during the study. Two different questionnaires were developed in order to investigate facilitators and barriers for the patients and for healthcare providers. The facilitators and barriers were ranked on a scale of 1\u201310 with 10 being the most important. Based on our power analysis, we aimed for a minimum of 300 completed questionnaires for the patients and a minimum of 90 completed questionnaires for the healthcare providers. Facilitators and barriers were analysed using frequencies, mean (SD) and ranking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>A total of 311 patients filled out the questionnaire of whom 86.8% underwent FET previously. The most important facilitator for the patients was to implement the strategy with the highest chance of pregnancy (mean 9.7; 95% CI 9.6\u20139.7) and the most important barrier was risk of missing ovulation (mean 8.4; 95% CI 8.2\u20138.6). A total of 96 healthcare providers filled out the questionnaire. According to healthcare providers, patients would accept the strategy when it causes less interference with their work and private life (mean 7.5; 95% CI 7.1\u20138.0) and has a low risk of missing the ovulation (mean 7.6; 95% CI 7.1\u20138.0). The most important facilitator for the implementation of home-based monitoring for healthcare providers was optimizing cumulative pregnancy rates (mean 8.1; 95% CI 7.7\u20138.4) and the most important barrier was the lack of laboratory capacity and flexibility (mean 6.4; 95% CI 5.8\u20137.0).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>Facilitators and barriers were selected based on expert opinion. Currently, there are no validated questionnaires that aim to assess facilitators and barriers for the implementation of treatments in fertility care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>During our study, we gained insight into barriers and facilitators for the implementation of home-based monitoring of NC-FET at an early phase. Early sharing and discussion of the results of this study with all stakeholders involved should stimulate a fast incorporation in guidelines, especially as key professionals in guideline development took part in this study. Also, based on our results, we can advise guideline developers to add tools to the guideline that may help overcome the implementation barriers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTERESTS<\/jats:title>\n                  <jats:p>The Antarctica-2 RCT is supported by a grant from the Netherlands Organisation for Health Research and Development (ZonMw 843002807). No authors have any competing interests to declare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>Trial NL6414 (NTR6590).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/hropen\/hoac021","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T22:21:34Z","timestamp":1654035694000},"source":"Crossref","is-referenced-by-count":3,"title":["Facilitators and barriers for home-based monitoring to time frozen embryo transfers in IVF among women and healthcare providers"],"prefix":"10.1093","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-3876","authenticated-orcid":false,"given":"T R","family":"Zaat","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Centre for Reproductive Medicine, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam , Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"de Bruin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Jeroen Bosch Ziekenhuis , 's-Hertogenbosch, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-5574","authenticated-orcid":false,"given":"F","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Centre for Reproductive Medicine, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam , Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-213X","authenticated-orcid":false,"given":"M","family":"van Wely","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Centre for Reproductive Medicine, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam , Amsterdam, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"2022061112561573800_hoac021-B1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bpa.2006.02.005","article-title":"The resistance to changing guidelines\u2014what are the challenges and how to meet them","volume":"20","author":"Bosse","year":"2006","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"2022061112561573800_hoac021-B2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"2022061112561573800_hoac021-B3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12913-016-1957-6","article-title":"The case of value-based healthcare for people living with complex long-term conditions","volume":"17","author":"Elf","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2022061112561573800_hoac021-B4","first-page":"2282","article-title":"Perinatal and maternal outcome after vitrification of blastocysts: a Nordic study in singletons from the CoNARTaS group","volume":"34","author":"Ernstad","year":"2019","journal-title":"Hum Reprod"},{"key":"2022061112561573800_hoac021-B5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/intqhc\/mzh030","article-title":"Determinants of innovation within health care organizations: literature review and Delphi study","volume":"16","author":"Fleuren","year":"2004","journal-title":"Int J Qual Health Care"},{"key":"2022061112561573800_hoac021-B6","first-page":"e1079","article-title":"Defining health in the era of value-based care: lessons from England of relevance to other health systems","volume":"9","author":"Gentry","year":"2017","journal-title":"Cureus"},{"key":"2022061112561573800_hoac021-B7","first-page":"CD006359","article-title":"Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes","volume":"10","author":"Glujovsky","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2022061112561573800_hoac021-B8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/humrep\/dew120","article-title":"A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer","volume":"31","author":"Groenewoud","year":"2016","journal-title":"Hum Reprod"},{"key":"2022061112561573800_hoac021-B9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients' care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"key":"2022061112561573800_hoac021-B10","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.5694\/j.1326-5377.2004.tb05948.x","article-title":"What drives change? Barriers to and incentives for achieving evidence-based practice","volume":"180","author":"Grol","year":"2004","journal-title":"Med J Aust"},{"key":"2022061112561573800_hoac021-B11","volume-title":"LimeSurvey: An Open Source Survey Tool","author":"LimeSurvey GmbH"},{"key":"2022061112561573800_hoac021-B12","author":"LIR","year":"2019"},{"key":"2022061112561573800_hoac021-B13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1740774513504150","article-title":"Does recruitment for multicenter clinical trials improve dissemination and timely implementation of their results? A survey study from the Netherlands","volume":"10","author":"Litjens","year":"2013","journal-title":"Clin Trials"},{"key":"2022061112561573800_hoac021-B14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.PHH.0000311888.06252.bb","article-title":"A glossary for dissemination and implementation research in health","volume":"14","author":"Rabin","year":"2008","journal-title":"J Public Health Manag Pract"},{"key":"2022061112561573800_hoac021-B15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/dez079","article-title":"Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus","volume":"34","author":"Saito","year":"2019","journal-title":"Hum Reprod"},{"key":"2022061112561573800_hoac021-B16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10815-017-0869-7","article-title":"Increased incidence of post-term delivery and Cesarean section after frozen-thawed embryo transfer during a hormone replacement cycle","volume":"34","author":"Saito","year":"2017","journal-title":"J Assist Reprod Genet"},{"key":"2022061112561573800_hoac021-B17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.fertnstert.2019.12.007","article-title":"Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications","volume":"113","author":"Singh","year":"2020","journal-title":"Fertil Steril"},{"key":"2022061112561573800_hoac021-B18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.118.12043","article-title":"Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum","volume":"73","author":"von Versen-Hoynck","year":"2019","journal-title":"Hypertension"},{"key":"2022061112561573800_hoac021-B19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fmed.2020.00104","article-title":"Increased risk of pre-eclampsia after frozen-thawed embryo transfer in programming cycles","volume":"7","author":"Wang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2022061112561573800_hoac021-B20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2014.05.027","article-title":"Cryopreservation of human embryos and its contribution to in vitro fertilization success rates","volume":"102","author":"Wong","year":"2014","journal-title":"Fertil Steril"},{"key":"2022061112561573800_hoac021-B21","doi-asserted-by":"crossref","first-page":"hoab026","DOI":"10.1093\/hropen\/hoab026","article-title":"ART in Europe, 2017: results generated from European registries by ESHRE","volume":"2021","author":"Wyns","year":"2021","journal-title":"Hum Reprod Open"},{"key":"2022061112561573800_hoac021-B22","first-page":"CD011184","article-title":"Fresh versus frozen embryo transfers in assisted reproduction","volume":"2","author":"Zaat","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2022061112561573800_hoac021-B23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.rbmo.2021.01.015","article-title":"Increased obstetric and neonatal risks in artificial cycles for frozen embryo transfers?","volume":"42","author":"Zaat","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2022061112561573800_hoac021-B24","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoab035","article-title":"Is home-based monitoring of ovulation to time frozen embryo transfer a cost-effective alternative for hospital-based monitoring of ovulation? Study protocol of the multicentre, non-inferiority Antarctica-2 randomised controlled trial","volume":"2021","author":"Zaat","year":"2021","journal-title":"Hum Reprod Open"},{"key":"2022061112561573800_hoac021-B25","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/humrep\/deaa040","article-title":"Home- or hospital-based monitoring to time frozen embryo transfer in the natural cycle? Patient-reported outcomes and experiences from the Antarctica-2 randomised controlled trial","volume":"35","author":"Zaat","year":"2020","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hropen\/advance-article-pdf\/doi\/10.1093\/hropen\/hoac021\/43891667\/hoac021.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2022\/3\/hoac021\/44022884\/hoac021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2022\/3\/hoac021\/44022884\/hoac021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T12:56:42Z","timestamp":1654952202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hropen\/article\/doi\/10.1093\/hropen\/hoac021\/6595105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5,19]]}},"URL":"https:\/\/doi.org\/10.1093\/hropen\/hoac021","relation":{},"ISSN":["2399-3529"],"issn-type":[{"value":"2399-3529","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2022,1,1]]},"article-number":"hoac021"}}